Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodiesFIGINI, M; FERRI, R; MEZZANZANICA, D et al.Gene therapy (Basingstoke). 2003, Vol 10, Num 12, pp 1018-1025, issn 0969-7128, 8 p.Article

Analysis of production, purification, and cytolytic potential of bi-specific antibodies reactive with ovarian-carcinoma-associated antigens and the T-cell antigen CD3VAN RAVENSWAAY CLAASEN, H. H; VAN DE GRIEND, R. J; MEZZANZANICA, D et al.International journal of cancer. 1993, Vol 55, Num 1, pp 128-136, issn 0020-7136Article

Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killingCONEY, L. R; MEZZANZANICA, D; SANBORN, D et al.Cancer research (Baltimore). 1994, Vol 54, Num 9, pp 2448-2455, issn 0008-5472Article

Possible targets on carcinoma for bMAb retargeting of lymphocyte or drug cytotoxicityCANEVARI, S; MEZZANZANICA, D; MENARD, S et al.International journal of cancer. Supplement. 1992, Num 7, pp 42-44, issn 0898-6924Conference Paper

Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies : role of different triggering moleculesFERRINI, S; CAMBIAGGI, A; CANTONI, C et al.International journal of cancer. Supplement. 1992, Num 7, pp 15-18, issn 0898-6924Conference Paper

CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinomaMAZZONI, A; MEZZANZANICA, D; JUNG, G et al.Cancer research (Baltimore). 1996, Vol 56, Num 23, pp 5443-5449, issn 0008-5472Article

Targeting of T lymphocytes against EGF-receptor⁺ tumor cells by bispecific monoclonal antibodies : requirement of CD3 molecule cross-linking for T-cell activationFERRINI, S; CAMBIAGGI, A; SFORZINI, S et al.International journal of cancer. 1993, Vol 55, Num 6, pp 931-937, issn 0020-7136Article

The Aspergillus toxin restrictocin is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma cellsCONDE, F. P; ORLANDI, R; CANEVARI, S et al.European journal of biochemistry (Print). 1989, Vol 178, Num 3, pp 795-802, issn 0014-2956Article

Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopyPISANU, M. E; RICCI, A; CANESE, R et al.British journal of cancer. 2014, Vol 110, Num 3, pp 625-635, issn 0007-0920, 11 p.Article

Panning phage antibody libraries on cells : Isolation of human Fab fragments against ovarian carcinoma using guided selectionFIGINI, M; OBICI, L; MEZZANZANICA, D et al.Cancer research (Baltimore). 1998, Vol 58, Num 5, pp 991-996, issn 0008-5472Article

Approaches to implement bispecific antibody treatment of ovarian carcinomaCANEVARI, S; MEZZANZANICA, D; MAZZONI, A et al.Cancer immunology and immunotherapy. 1997, Vol 45, Num 3-4, pp 187-189, issn 0340-7004Conference Paper

A critical comparison of three internalization assays applied to the evaluation of a given mAb as a toxin-carrier candidateCASALINI, P; CALDERA, M; CANEVARI, S et al.Cancer immunology and immunotherapy. 1993, Vol 37, Num 1, pp 54-60, issn 0340-7004Article

Human ovarian carcinoma lysis by cytotoxic T cells targeted by bispecific monoclonal antibodies: analysis of the antibody componentsMEZZANZANICA, D; CANEVARI, S; MENARD, S et al.International journal of cancer. 1988, Vol 41, Num 4, pp 609-615, issn 0020-7136Article

Development of a new vaccine formulation that enhances the immunogenicity of tumor-associated antigen CaMBr1PERICO, M. E; MEZZANZANICA, D; LUISON, E et al.Cancer immunology and immunotherapy. 2000, Vol 49, Num 6, pp 296-304, issn 0340-7004Article

Use of combination of monoclonal antibodies directed against three distinct epitopes of a tumor associated antigen : analysis of cell binding and internalizationCASALINI, P; MEZZANZANICA, D; CANEVARI, S et al.International journal of cancer. 1991, Vol 48, Num 2, pp 284-290, issn 0020-7136, 7 p.Article

Human peripheral blood lymphocytes targeted with bispecific antibodies release cytokines that are essential for inhibiting tumor growthJIA-HUA QIAN; TITUS, J. A; ANDREW, S. M et al.The Journal of immunology (1950). 1991, Vol 146, Num 9, pp 3250-3256, issn 0022-1767Article

Activation of mononuclear cells to be used for hybrid monoclonal antibody-induced lysis of human ovarian carcinoma cellsPUPA, S. M; CANEVARI, S; FONTANELLI, R et al.International journal of cancer. 1988, Vol 42, Num 3, pp 455-459, issn 0020-7136Article

Human carcinoma cell lines xenografted in athymic mice: biological and antigenic characteristics of an intraabdominal modelRIPAMONTI, M; CANEVARI, S; MENARD, S et al.Cancer immunology and immunotherapy. 1987, Vol 24, Num 1, pp 13-18, issn 0340-7004Article

Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancerGRANATA, A; NICOLETTI, R; MEZZANZANICA, D et al.British journal of cancer. 2014, Vol 110, Num 2, pp 330-340, issn 0007-0920, 11 p.Article

A step further in understanding the biology of the folate receptor in ovarian carcinomaBAGNOLI, M; CANEVARI, S; FIGINI, M et al.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp S140-S144, issn 0090-8258, 2Conference Paper

Efficiency of T cell triggering by anti-CD3 monoclonal antibodies (mAb) with potential usefulness in bispecific mAb generationJACOBS, N; MAZZONI, A; MEZZANZANICA, D et al.Cancer immunology and immunotherapy. 1997, Vol 44, Num 5, pp 257-264, issn 0340-7004Article

Targeting of anti-tumor responses with bispecific antibodiesSEGAL, D. M; QIAN, J.-H; MEZZANZANICA, D et al.Immunobiology (1979). 1992, Vol 185, Num 2-4, pp 390-402, issn 0171-2985Conference Paper

Immunoconjugate generation between the ribosome inactivating protein restrictocin and an anti-human breast carcinoma MABORLANDI, R; CANEVARI, S; CONDE, F. P et al.Cancer immunology and immunotherapy. 1988, Vol 26, Num 2, pp 114-120, issn 0340-7004Article

Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificityMIOTTI, S; CANEVARI, S; MENARD, S et al.International journal of cancer. 1987, Vol 39, Num 3, pp 297-303, issn 0020-7136Article

Change in binding reactivity of an anti-tumor monoclonal antibody after the introduction of 2-pyridyl disulphide groupsORLANDI, R; CANEVARI, S; LEONI, F et al.Hybridoma. 1986, Vol 5, Num 1, pp 1-8, issn 0272-457XArticle